Psychometric validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients

N. Bonner, L. Abetz, J. Meunier, M. Sikirica (Bollington, United Kingdom; Lyon, France; Berlin, Germany)

Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Session: Pulmonary circulation: clinical end-points and clinical physiology
Session type: Thematic Poster Session
Number: 3921
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Bonner, L. Abetz, J. Meunier, M. Sikirica (Bollington, United Kingdom; Lyon, France; Berlin, Germany). Psychometric validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients. Eur Respir J 2012; 40: Suppl. 56, 3921

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Pulmonary rehabilitation in patients with pulmonary arterial hypertension
Source: ERS Course 2017
Year: 2017

The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007



COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Year: 2020



Risk assessment in pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017
Year: 2018



Risk assessment in pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018
Year: 2018



Risk assessment in pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 390-398
Year: 2016



Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

Exercise pathophysiology in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007


Functional impact of exercise pulmonary hypertension in patients with borderline pulmonary arterial pressure
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension
Source: Eur Respir J, 50 (3) 1700784; 10.1183/13993003.00784-2017
Year: 2017



Physician/patient reporting of depression/anxiety in a US pulmonary arterial hypertension population
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 5 (1) 00218-2018; 10.1183/23120541.00218-2018
Year: 2019



Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Year: 2020



Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 608-616
Year: 2011



Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003



Characteristics of Japanese elderly patients with pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019